Daily Stock Opinions and Ratings

Opinions

Jean-Francois Tardif Futuremed Healthcare FMD-T COMMENT Dec 27, 2006

Sold his holdings. Really like the company because it was health care and not cyclical. Long-term outlook is really great. Good management. Price has dropped and he expects at some time he will own it again. Will look at the next quarter’s results.

Jean-Francois Tardif

Unlock Rating

$9.580

Stock price when the opinion was issued

biotechnology pharmaceutical

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

TOP PICK

He supplied provider to hospitals, nursing homes, et cetera. Healthcare sector so very protected in the event of a recession. Growing between 5% and 15% annually. Generates a lot of free cash flow. Distribution of around $.92 giving a 10% yield plus 10% growth.

COMMENT

Sells supplies to nursing homes, which is a growth industry long-term. Good management team.

TOP PICK

Distributor of medical products, mostly in Ontario. Just bought a Quebec company, which should grow revenues and margin expansion. 12% distribution is likely to be increased this year. Earnings per share should grow at 10%-20% also.

TOP PICK

Distribution services for nursing homes. Generates a lot of free cash flow. Nursing homes are a growing market. Recession resistant. 13% distribution.

TOP PICK

Conservative name trading at 10-11 times PE. Entrepreneurial management team with ownership in the company. Strong market share in the distribution business in healthcare and long term care facilities.

TOP PICK

Distributes supplies such as wound management, chairs, furniture, etc. to retirement homes. Well run. Have already cut their distributions. Trades at 6 times EBITDA.

COMMENT

Rarely sells after an earnings disappointment. Doesn’t think there is a structural problem with the business. They need to get some clarity on how they will transition into what is in effect a new business model where they will have a growth side.

WATCH

Distribute healthcare products primarily to retirement homes. Started to see more competition in the 2nd quarter and intensified in the 3rd quarter. Cut distributions once but may do another cut. He’ll wait for Q4 results.

PAST TOP PICK

(A Top Pick Dec 16/09. Down 14.43%.) Supplies to seniors’ homes. Pays a yield of 9%. Missed their growth objectives so he sold his holdings.

PAST TOP PICK

(A Top Pick July 7/10. Down 10.07%.) Sold his holdings.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Jean-Francois Tardif Futuremed Healthcare FMD-T COMMENT Dec 27, 2006

You might be interested:

Futuremed Healthcare(FMD-T)

Futuremed Healthcare(FMD-T)

Futuremed Healthcare(FMD-T)

Futuremed Healthcare(FMD-T)

Futuremed Healthcare(FMD-T)

Futuremed Healthcare(FMD-T)

Futuremed Healthcare(FMD-T)

Futuremed Healthcare(FMD-T)

Futuremed Healthcare(FMD-T)

Futuremed Healthcare(FMD-T)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Bruce Murray

The Panic-Proof Portfolio (Stockchase Research)

The Weekly Buzzing Stocks by Billy Kawasaki

Chris Blumas

Stockchase Insights